Earnings
ODT
3.430
+3.31%
0.110
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
157.26M
--
--
--
--
--
0.00
--
--
--
2.61M
--
159.87M
6.30M
--
--
--
--
--
--
1.71M
8.01M
167.89M
--
14.17M
0.00
--
--
--
--
--
12.90M
--
--
--
--
27.07M
0.00
--
--
--
4.67M
4.67M
31.74M
367.00K
502.20M
-366.43M
--
--
--
136.15M
136.15M
167.89M
FY 2019-12-31
180.46M
--
--
--
--
--
0.00
--
--
--
3.47M
--
183.93M
3.24M
--
--
--
--
--
--
1.66M
4.90M
188.83M
--
15.58M
0.00
--
--
--
--
--
9.20M
--
--
--
--
24.78M
0.00
--
--
--
1.75M
1.75M
26.53M
300.00K
402.08M
-240.08M
--
--
--
162.30M
162.30M
188.83M
FY 2018-12-31
139.05M
--
--
--
--
--
0.00
--
--
--
750.00K
--
139.80M
1.90M
--
--
--
--
--
--
974.00K
2.87M
142.67M
--
10.78M
0.00
--
--
--
--
--
7.37M
--
--
--
66.00K
18.21M
0.00
--
--
--
461.00K
461.00K
18.67M
244.00K
252.01M
-128.25M
--
--
--
124.00M
124.00M
142.67M
FY 2017-12-31
198.10M
--
--
--
--
--
0.00
--
--
--
4.84M
--
202.95M
165.00K
--
--
--
--
--
--
383.00K
548.00K
203.49M
--
4.30M
0.00
--
--
--
--
--
3.21M
--
--
--
--
7.51M
0.00
--
--
--
--
0.00
7.51M
240.00K
235.03M
-39.29M
--
--
--
195.98M
195.98M
203.49M
FY 2016-12-31
2.60M
--
--
--
--
--
0.00
--
--
--
268.00K
--
2.87M
14.00K
--
--
--
--
--
--
0.00
14.00K
2.88M
--
572.00K
0.00
--
--
--
--
--
26.00K
--
--
--
--
598.00K
0.00
--
--
--
--
0.00
598.00K
7.77M
1.06M
-6.55M
--
--
--
2.28M
2.28M
2.88M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out ODT latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Odonate Therapeutics Inc recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.